Anthony L Sinn - JoVE Visualize

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

Blood|September 4, 2020

The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cellsLijian Shao, Adedamola Elujoba-Bridenstine, Katherine E Zink, et al.

Journal of Medicinal Chemistry|August 20, 2011

Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasisFang Wang, Jing Li, Anthony L Sinn, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 6, 2021

Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cellsJiao Wang, Sandra Toregrosa-Allen, Bennett D Elzey, et al.

Cancer Immunology, Immunotherapy : CII|December 24, 2013

Soypeptide lunasin in cytokine immunotherapy for lymphomaHua-Chen Chang, David Lewis, Chun-Yu Tung, et al.

Transplantation and Cellular Therapy|November 19, 2022

Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft SourceBrian H Johnstone, John R Woods, W Scott Goebel, et al.

Scientific Reports|June 6, 2023

Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusionNur P Damayanti, M Reza Saadatzadeh, Erika Dobrota, et al.

Molecular Cancer Therapeutics|October 24, 2015

Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic ModelEva Tonsing-Carter, Barbara J Bailey, M Reza Saadatzadeh, et al.

Cancers|August 30, 2020

Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for OsteosarcomaPankita H Pandya, Lijun Cheng, M Reza Saadatzadeh, et al.

Cancers|January 8, 2023

Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid TumorsPankita H Pandya, Asha Jacob Jannu, Khadijeh Bijangi-Vishehsaraei, et al.

Neoplasia (New York, N.Y.)|January 16, 2026

Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcomaFarinaz Barghi, M Reza Saadatzadeh, Erika A Dobrota, et al.

Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

Blood|September 4, 2020

The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cellsLijian Shao, Adedamola Elujoba-Bridenstine, Katherine E Zink, et al.

Journal of Medicinal Chemistry|August 20, 2011

Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasisFang Wang, Jing Li, Anthony L Sinn, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 6, 2021

Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cellsJiao Wang, Sandra Toregrosa-Allen, Bennett D Elzey, et al.

Cancer Immunology, Immunotherapy : CII|December 24, 2013

Soypeptide lunasin in cytokine immunotherapy for lymphomaHua-Chen Chang, David Lewis, Chun-Yu Tung, et al.

Transplantation and Cellular Therapy|November 19, 2022

Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft SourceBrian H Johnstone, John R Woods, W Scott Goebel, et al.

Scientific Reports|June 6, 2023

Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusionNur P Damayanti, M Reza Saadatzadeh, Erika Dobrota, et al.

Molecular Cancer Therapeutics|October 24, 2015

Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic ModelEva Tonsing-Carter, Barbara J Bailey, M Reza Saadatzadeh, et al.

Cancers|August 30, 2020

Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for OsteosarcomaPankita H Pandya, Lijun Cheng, M Reza Saadatzadeh, et al.

Cancers|January 8, 2023

Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid TumorsPankita H Pandya, Asha Jacob Jannu, Khadijeh Bijangi-Vishehsaraei, et al.

Neoplasia (New York, N.Y.)|January 16, 2026

Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcomaFarinaz Barghi, M Reza Saadatzadeh, Erika A Dobrota, et al.

Pageof 3